Granules India Limited (BOM: 532482)
India
· Delayed Price · Currency is INR
591.80
-8.40 (-1.40%)
At close: Dec 20, 2024
Granules India Revenue
Granules India had revenue of 9.67B INR in the quarter ending September 30, 2024, a decrease of -18.74%. This brings the company's revenue in the last twelve months to 44.78B, down -0.86% year-over-year. In the fiscal year ending March 31, 2024, Granules India had annual revenue of 45.06B, down -0.12%.
Revenue (ttm)
44.78B
Revenue Growth
-0.86%
P/S Ratio
3.20
Revenue / Employee
11.04M
Employees
4,057
Market Cap
143.43B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 45.06B | -55.50M | -0.12% |
Mar 31, 2023 | 45.12B | 7.47B | 19.84% |
Mar 31, 2022 | 37.65B | 5.27B | 16.29% |
Mar 31, 2021 | 32.38B | 6.39B | 24.59% |
Mar 31, 2020 | 25.99B | 3.19B | 14.02% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionGranules India News
- 1 day ago - Granules India large trade: 1.3% equity worth Rs 191 crore changes hands - Business Upturn
- 4 days ago - Granules India receives USFDA approval for Lisdexamfetamine Dimesylate Chewable tablets - Business Upturn
- 17 days ago - Compliance issues at Granules India’s Gagillapur plant - The Times of India
- 18 days ago - Granules India says US FDA action may impact new product approvals, expect meet with FDA soon - Business Upturn
- 18 days ago - Granules India stock falls over 10% from day’s high as US FDA classifies inspection as “Official Action Indicated” - Business Upturn
- 18 days ago - Granules India’s Gagillapur facility receives OAI classification from US FDA - Business Upturn
- 24 days ago - Granules India achieves SBTi approval for ambitious net-zero goals - The Times of India
- 6 weeks ago - Granules India’s Unit V facility in Andhra Pradesh gets US FDA EIR with NAI status - The Times of India